Clinical Trial Update: Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 vaccine therapy trial for recurrent prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Prostate, Recurrent Prostate Cancer | Phase 2 | Status: COMPLETED